Display Settings:

Format

Send to:

Choose Destination
    Praxis (Bern 1994). 2001 Mar 8;90(10):403-6.

    [New aspects of immunotherapy of malignant melanoma].

    [Article in German]

    Source

    Hautklinik der Johannes Gutenberg-Universität Mainz.

    Abstract

    Malignant melanoma is a fatal disease in its terminal stage. Despite of all attempts to prolong the life of the patient with chemo- or chemoimmunotherapies, the course of the disease is rarely affected. Specific immunotherapies with antigen-pulsed DC might be a reason for optimism. DC are professional antigen-presenting cells with a capability to process and present melanoma antigens. First vaccination studies show encouraging results with complete remissions even in progressed cases.

    PMID:
    11305186
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk